CLINICAL DEVELOPMENT STRATEGY & PIVOTAL TRIAL DESIGN
We design decision-grade development architecture, pivotal strategy
and protocol logic before cost, timelines and assumptions harden.
THE DESIGN QUESTION
Choose endpoints, estimands and
analysis logic that answer the
development question.
Define the right patients,
comparators and enrichment
assumptions.
Build feasibility, country mix and
operational logic into the design
from the start.
OUR DESIGN PATHWAY
Assess the evidence,
objectives and key
uncertainties.
Set the target product
profile, trial objectives
and decision criteria.
Design the study,
endpoints, population
and statistical logic.
Challenge assumptions,
run scenarios and
mitigate key risks.
Prepare for regulator,
payer and KOL input
and build consensus.
Refine the protocol
and supporting
documents for execution.
WHAT WE OFTEN CHANGE FIRST
From a broad or ambiguous objective to a sharp, decision-focused question.
From multiple or misaligned endpoints to a clear, hierarchical and justified endpoint strategy.
From optimistic or unproven assumptions to evidence-based, stress-tested scenarios.
From idealised site and country plans to a realistic, operationally credible design.
From late-stage design changes to the right investments at the right time.
Copyright © 2026 Manolo Beelke & Partners. All rights reserved.
